| Code | 0300F | ||||||||||
| MA number | 42/0126/25-S | ||||||||||
| Product Form: | tbl bma 2x50 mg (blis. Al/Al) - jednotk.bal. | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Mutual recognition procedure | ||||||||||
| MAH, country: | Vectans Pharma, France | ||||||||||
| Therapeutic Class: | 42 - CHEMOTHERAPEUTICA (VRATANE TUBERKULOSTATIK) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister Al/Al | ||||||||||
| Route of admin.: | Buccal use |
| Prescription Status: | Medicinal product not subject to medical prescription. |
| Legal basis: | Article 8(3) application - known active substance |
| MA issued: | 05.07.2025 |
| Validity: | 05.07.2030 |
| SPC: |
SPC_Bravilon_tbl bma_06/2025_REG.pdf
|
| PIL: |
PIL_Bravilon_tbl bma_06/2025_REG.pdf
|
| Safety feature | Unknown |
| Data update: | 11.07.2025 |
